KalVista Pharmaceuticals
KALV
KALV
117 hedge funds and large institutions have $605M invested in KalVista Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 44 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.7% more ownership
Funds ownership: 91.33% → 97.03% (+5.7%)
57% less call options, than puts
Call options by funds: $3.59M | Put options by funds: $8.29M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
117
Holding in Top 10
1
Calls
$3.59M
Puts
$8.29M
Top Buyers
| 1 | +$26.2M | |
| 2 | +$25.9M | |
| 3 | +$25M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$22.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$19.3M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$19.7M | |
| 3 | -$9.3M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$8.93M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$7.89M |